Selected research
Industry Research
Custom Assay Development Service Industry Research Report 2026
Market perspective
The global Custom Assay Development Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Custom Assay Development Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Custom Assay Development Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Custom Assay Development Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Custom Assay Development Service include Eurofins Scientific, PerkinElmer, Champions Oncology, Inc, Precision for Medicine, Sygnature Discovery, Merck KGaA, Plexbio, Cygnus Technologies and Luminex Corporation, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Custom Assay Development Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Custom Assay Development Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Custom Assay Development Service Market by Company
Eurofins Scientific
PerkinElmer
Champions Oncology, Inc
Precision for Medicine
Sygnature Discovery
Merck KGaA
Plexbio
Cygnus Technologies
Luminex Corporation
Gyros Protein Technologies AB
Mission Bio
Camtech Innovations
ProteoGenix
Selvita
Multispan, Inc.
Capra Science
Agena Bioscience, Inc.
Celemics, Inc.
Custom Assay Development Service Segment by Type
Cell-based
Antibody-based
Others
Custom Assay Development Service Segment by Application
Pharmacy
Biology
Scientific Research
Others
Custom Assay Development Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Assay Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Assay Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Assay Development Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Custom Assay Development Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cell-based
- Antibody-based
- Others
Applications
- Pharmacy
- Biology
- Scientific Research
- Others
Companies covered
- Eurofins Scientific
- PerkinElmer
- Champions Oncology, Inc
- Precision for Medicine
- Sygnature Discovery
- Merck KGaA
- Plexbio
- Cygnus Technologies
- Luminex Corporation
- Gyros Protein Technologies AB
- Mission Bio
- Camtech Innovations
- ProteoGenix
- Selvita
- Multispan, Inc.
- Capra Science
- Agena Bioscience, Inc.
- Celemics, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Custom Assay Development Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cell-based
- 2.2.3 Antibody-based
- 2.2.4 Others
- 2.3 Custom Assay Development Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmacy
- 2.3.3 Biology
- 2.3.4 Scientific Research
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Custom Assay Development Service Breakdown Data by Type
- 3.1 Global Custom Assay Development Service Historic Market Size by Type (2021-2026)
- 3.2 Global Custom Assay Development Service Forecasted Market Size by Type (2027-2032)
4 Custom Assay Development Service Breakdown Data by Application
- 4.1 Global Custom Assay Development Service Historic Market Size by Application (2021-2026)
- 4.2 Global Custom Assay Development Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Custom Assay Development Service Market Perspective (2021-2032)
- 5.2 Global Custom Assay Development Service Growth Trends by Region
- 5.2.1 Global Custom Assay Development Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Custom Assay Development Service Historic Market Size by Region (2021-2026)
- 5.2.3 Custom Assay Development Service Forecasted Market Size by Region (2027-2032)
- 5.3 Custom Assay Development Service Market Dynamics
- 5.3.1 Custom Assay Development Service Industry Trends
- 5.3.2 Custom Assay Development Service Market Drivers
- 5.3.3 Custom Assay Development Service Market Challenges
- 5.3.4 Custom Assay Development Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Custom Assay Development Service Players by Revenue
- 6.1.1 Global Top Custom Assay Development Service Players by Revenue (2021-2026)
- 6.1.2 Global Custom Assay Development Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Custom Assay Development Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Custom Assay Development Service Head Office and Area Served
- 6.4 Global Custom Assay Development Service Players, Product Type & Application
- 6.5 Global Custom Assay Development Service Manufacturers Established Date
- 6.6 Global Custom Assay Development Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Custom Assay Development Service Market Size (2021-2032)
- 7.2 North America Custom Assay Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Custom Assay Development Service Market Size by Country (2021-2026)
- 7.4 North America Custom Assay Development Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Custom Assay Development Service Market Size (2021-2032)
- 8.2 Europe Custom Assay Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Custom Assay Development Service Market Size by Country (2021-2026)
- 8.4 Europe Custom Assay Development Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Custom Assay Development Service Market Size (2021-2032)
- 9.2 Asia-Pacific Custom Assay Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Custom Assay Development Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Custom Assay Development Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Custom Assay Development Service Market Size (2021-2032)
- 10.2 South America Custom Assay Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Custom Assay Development Service Market Size by Country (2021-2026)
- 10.4 South America Custom Assay Development Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Custom Assay Development Service Market Size (2021-2032)
- 11.2 Middle East & Africa Custom Assay Development Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Custom Assay Development Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Custom Assay Development Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Scientific
- 12.1.1 Eurofins Scientific Company Information
- 12.1.2 Eurofins Scientific Business Overview
- 12.1.3 Eurofins Scientific Revenue in Custom Assay Development Service Business (2021-2026)
- 12.1.4 Eurofins Scientific Custom Assay Development Service Product Portfolio
- 12.1.5 Eurofins Scientific Recent Developments
- 12.2 PerkinElmer
- 12.2.1 PerkinElmer Company Information
- 12.2.2 PerkinElmer Business Overview
- 12.2.3 PerkinElmer Revenue in Custom Assay Development Service Business (2021-2026)
- 12.2.4 PerkinElmer Custom Assay Development Service Product Portfolio
- 12.2.5 PerkinElmer Recent Developments
- 12.3 Champions Oncology, Inc
- 12.3.1 Champions Oncology, Inc Company Information
- 12.3.2 Champions Oncology, Inc Business Overview
- 12.3.3 Champions Oncology, Inc Revenue in Custom Assay Development Service Business (2021-2026)
- 12.3.4 Champions Oncology, Inc Custom Assay Development Service Product Portfolio
- 12.3.5 Champions Oncology, Inc Recent Developments
- 12.4 Precision for Medicine
- 12.4.1 Precision for Medicine Company Information
- 12.4.2 Precision for Medicine Business Overview
- 12.4.3 Precision for Medicine Revenue in Custom Assay Development Service Business (2021-2026)
- 12.4.4 Precision for Medicine Custom Assay Development Service Product Portfolio
- 12.4.5 Precision for Medicine Recent Developments
- 12.5 Sygnature Discovery
- 12.5.1 Sygnature Discovery Company Information
- 12.5.2 Sygnature Discovery Business Overview
- 12.5.3 Sygnature Discovery Revenue in Custom Assay Development Service Business (2021-2026)
- 12.5.4 Sygnature Discovery Custom Assay Development Service Product Portfolio
- 12.5.5 Sygnature Discovery Recent Developments
- 12.6 Merck KGaA
- 12.6.1 Merck KGaA Company Information
- 12.6.2 Merck KGaA Business Overview
- 12.6.3 Merck KGaA Revenue in Custom Assay Development Service Business (2021-2026)
- 12.6.4 Merck KGaA Custom Assay Development Service Product Portfolio
- 12.6.5 Merck KGaA Recent Developments
- 12.7 Plexbio
- 12.7.1 Plexbio Company Information
- 12.7.2 Plexbio Business Overview
- 12.7.3 Plexbio Revenue in Custom Assay Development Service Business (2021-2026)
- 12.7.4 Plexbio Custom Assay Development Service Product Portfolio
- 12.7.5 Plexbio Recent Developments
- 12.8 Cygnus Technologies
- 12.8.1 Cygnus Technologies Company Information
- 12.8.2 Cygnus Technologies Business Overview
- 12.8.3 Cygnus Technologies Revenue in Custom Assay Development Service Business (2021-2026)
- 12.8.4 Cygnus Technologies Custom Assay Development Service Product Portfolio
- 12.8.5 Cygnus Technologies Recent Developments
- 12.9 Luminex Corporation
- 12.9.1 Luminex Corporation Company Information
- 12.9.2 Luminex Corporation Business Overview
- 12.9.3 Luminex Corporation Revenue in Custom Assay Development Service Business (2021-2026)
- 12.9.4 Luminex Corporation Custom Assay Development Service Product Portfolio
- 12.9.5 Luminex Corporation Recent Developments
- 12.10 Gyros Protein Technologies AB
- 12.10.1 Gyros Protein Technologies AB Company Information
- 12.10.2 Gyros Protein Technologies AB Business Overview
- 12.10.3 Gyros Protein Technologies AB Revenue in Custom Assay Development Service Business (2021-2026)
- 12.10.4 Gyros Protein Technologies AB Custom Assay Development Service Product Portfolio
- 12.10.5 Gyros Protein Technologies AB Recent Developments
- 12.11 Mission Bio
- 12.11.1 Mission Bio Company Information
- 12.11.2 Mission Bio Business Overview
- 12.11.3 Mission Bio Revenue in Custom Assay Development Service Business (2021-2026)
- 12.11.4 Mission Bio Custom Assay Development Service Product Portfolio
- 12.11.5 Mission Bio Recent Developments
- 12.12 Camtech Innovations
- 12.12.1 Camtech Innovations Company Information
- 12.12.2 Camtech Innovations Business Overview
- 12.12.3 Camtech Innovations Revenue in Custom Assay Development Service Business (2021-2026)
- 12.12.4 Camtech Innovations Custom Assay Development Service Product Portfolio
- 12.12.5 Camtech Innovations Recent Developments
- 12.13 ProteoGenix
- 12.13.1 ProteoGenix Company Information
- 12.13.2 ProteoGenix Business Overview
- 12.13.3 ProteoGenix Revenue in Custom Assay Development Service Business (2021-2026)
- 12.13.4 ProteoGenix Custom Assay Development Service Product Portfolio
- 12.13.5 ProteoGenix Recent Developments
- 12.14 Selvita
- 12.14.1 Selvita Company Information
- 12.14.2 Selvita Business Overview
- 12.14.3 Selvita Revenue in Custom Assay Development Service Business (2021-2026)
- 12.14.4 Selvita Custom Assay Development Service Product Portfolio
- 12.14.5 Selvita Recent Developments
- 12.15 Multispan, Inc.
- 12.15.1 Multispan, Inc. Company Information
- 12.15.2 Multispan, Inc. Business Overview
- 12.15.3 Multispan, Inc. Revenue in Custom Assay Development Service Business (2021-2026)
- 12.15.4 Multispan, Inc. Custom Assay Development Service Product Portfolio
- 12.15.5 Multispan, Inc. Recent Developments
- 12.16 Capra Science
- 12.16.1 Capra Science Company Information
- 12.16.2 Capra Science Business Overview
- 12.16.3 Capra Science Revenue in Custom Assay Development Service Business (2021-2026)
- 12.16.4 Capra Science Custom Assay Development Service Product Portfolio
- 12.16.5 Capra Science Recent Developments
- 12.17 Agena Bioscience, Inc.
- 12.17.1 Agena Bioscience, Inc. Company Information
- 12.17.2 Agena Bioscience, Inc. Business Overview
- 12.17.3 Agena Bioscience, Inc. Revenue in Custom Assay Development Service Business (2021-2026)
- 12.17.4 Agena Bioscience, Inc. Custom Assay Development Service Product Portfolio
- 12.17.5 Agena Bioscience, Inc. Recent Developments
- 12.18 Celemics, Inc.
- 12.18.1 Celemics, Inc. Company Information
- 12.18.2 Celemics, Inc. Business Overview
- 12.18.3 Celemics, Inc. Revenue in Custom Assay Development Service Business (2021-2026)
- 12.18.4 Celemics, Inc. Custom Assay Development Service Product Portfolio
- 12.18.5 Celemics, Inc. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst